Saturday 17 October 2026
Export DGX’s income statement to Excel — free account
Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
235.00
4.15
−1.74%
Follow DGX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
19.56 | 19.39 | 18.55 | 19.33 | 10.90 | 11.24 | 16.79 | 15.45 | 17.57 | 20.23 |
Piotroski F-Score |
8 | 4 | 5 | 4 | 8 | 9 | 7 | 5 | 7 | 5 |
P/S ratio |
1.75 | 1.70 | 1.70 | 1.83 | 2.00 | 1.69 | 1.85 | 1.50 | 1.83 | 1.79 |
Altman Z-Score |
3.15 | 2.79 | 3.09 | 3.65 | 4.06 | 3.50 | 3.06 | 3.16 | 3.51 | 3.53 |
Altman Z″-Score (non-manufacturers) |
3.53 | 3.31 | 3.78 | 3.93 | 4.44 | 4.70 | 3.81 | 3.83 | 4.05 | 4.24 |
P/FCF ratio |
14.17 | 18.42 | 18.25 | 13.75 | 11.82 | 10.06 | 16.97 | 13.86 | 14.68 | 15.73 |
Beneish M-Score |
(2.65) | (2.54) | (2.56) | (2.85) | (2.58) | (2.30) | (2.61) | (2.54) | (2.63) | (2.57) |
P/Operating CF |
41.42 | 36.09 | 29.93 | 54.10 | 44.96 | 29.52 | 41.12 | 38.39 | 41.95 | 36.87 |
Dividend Safety Score |
85 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.67 | 2.46 | 2.49 | 3.05 | 3.34 | 2.35 | 2.52 | 2.15 | 2.73 | 2.78 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.22 | 2.27 | 2.14 | 2.20 | 2.30 | 1.99 | 2.32 | 2.00 | 2.32 | 2.26 |
EV/EBITDA |
11.53 | 12.19 | 11.64 | 11.65 | 8.88 | 8.07 | 11.47 | 10.70 | 11.98 | 10.69 |
EV/Operating CF |
13.00 | 16.80 | 15.57 | 12.65 | 11.09 | 9.39 | 14.39 | 12.57 | 14.64 | 14.62 |
EV/FCF |
18.04 | 24.66 | 22.92 | 16.54 | 13.53 | 11.86 | 21.22 | 18.46 | 18.63 | 19.83 |
Quick Ratio |
0.80 | 0.85 | 1.04 | 0.97 | 1.32 | 1.51 | 1.13 | 0.77 | 1.00 | 1.31 |
Current Ratio |
1.04 | 1.10 | 1.31 | 1.22 | 1.56 | 1.72 | 1.25 | 0.94 | 1.24 | 1.56 |
Net Debt/EBITDA |
2.47 | 3.08 | 2.37 | 1.97 | 1.13 | 1.23 | 2.29 | 2.67 | 2.54 | 2.21 |
Debt/Assets |
34.95% | 38.49% | 33.61% | 31.00% | 29.48% | 28.63% | 37.14% | 35.38% | 36.03% | 36.97% |
Debt/Equity |
0.79 | 0.91 | 0.74 | 0.67 | 0.62 | 0.59 | 0.84 | 0.74 | 0.76 | 0.80 |
Asset Turnover |
0.68 | 0.65 | 0.69 | 0.75 | 0.78 | 0.70 | 0.65 | 0.70 | 0.72 | 0.72 |
Operating CF/Net income |
1.91 | 1.54 | 1.50 | 1.82 | 1.12 | 1.41 | 1.45 | 1.63 | 1.52 | 1.74 |
Capex/Depreciation |
(0.92) | (0.86) | (0.93) | (0.92) | (0.99) | (1.16) | (1.22) | (1.24) | (0.93) | (1.18) |
Interest Coverage |
5.89 | 6.70 | 8.30 | 10.35 | 15.77 | 12.09 | 7.03 | 6.59 | 7.72 | 8.93 |
| 14.10% | 13.17% | 13.85% | 15.18% | 29.91% | 22.81% | 15.67% | 14.40% | 16.06% | 13.70% | |
| 6.10% | 5.74% | 6.33% | 7.12% | 14.39% | 10.61% | 7.20% | 6.84% | 7.49% | 6.40% | |
ROIC |
7.81% | 6.74% | 7.61% | 9.30% | 15.46% | 12.74% | 8.30% | 7.62% | 8.46% | 9.93% |
Return on Tangible Assets |
42.90% | 37.07% | 35.82% | 44.58% | 73.77% | 48.99% | 43.93% | 61.69% | 55.38% | 40.66% |
Average Days of Receivables |
46.57 | 48.21 | 47.74 | 44.13 | 48.65 | 58.79 | 50.22 | 49.05 | 45.56 | 46.85 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
17.83% | 17.93% | 17.75% | 18.96% | 16.01% | 16.42% | 18.86% | 18.91% | 19.49% | 19.13% |
Intangible Assets out of Total Assets |
0.65 | 0.66 | 0.63 | 0.65 | 0.61 | 0.57 | 0.60 | 0.71 | 0.71 | 0.69 |
Share Based Compensation of Revenue |
0.80% | 0.89% | 0.83% | 0.78% | 0.73% | 1.03% | 0.72% | 0.81% | 1.07% | 0.96% |
Graham Net Nets |
(0.34) | (0.41) | (0.34) | (0.28) | (0.20) | (0.26) | (0.33) | (0.38) | (0.31) | (0.30) |
Graham Number |
113.83 | 103.65 | 98.34 | 96.28 | 136.09 | 110.09 | 77.93 | 68.53 | 67.69 | 58.50 |
Earnings Yield |
5.11% | 5.16% | 5.39% | 5.17% | 9.17% | 8.89% | 5.96% | 6.47% | 5.69% | 4.94% |
Free Cash Flow Yield |
7.06% | 5.43% | 5.48% | 7.27% | 8.46% | 9.94% | 5.89% | 7.21% | 6.81% | 6.36% |
Revenue per Share |
99.41 | 88.94 | 82.61 | 85.20 | 86.30 | 70.43 | 57.66 | 55.38 | 54.03 | 51.53 |
Operating CF per Share |
16.99 | 12.02 | 11.36 | 14.81 | 17.86 | 14.96 | 9.28 | 8.82 | 8.58 | 7.97 |
Capex per Share |
(4.75) | (3.83) | (3.64) | (3.48) | (3.22) | (3.12) | (2.99) | (2.82) | (1.84) | (2.09) |
Free Cash Flow per Share |
12.24 | 8.19 | 7.71 | 11.33 | 14.64 | 11.84 | 6.29 | 6.01 | 6.74 | 5.88 |
Cash per Share |
3.78 | 4.95 | 6.13 | 2.72 | 6.98 | 8.64 | 8.90 | 0.99 | 1.00 | 2.56 |
Shareholders Equity per Share |
64.92 | 61.38 | 56.63 | 51.12 | 51.86 | 50.81 | 42.44 | 38.73 | 36.17 | 33.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
64.92 | 61.38 | 56.63 | 51.12 | 51.86 | 50.81 | 42.44 | 38.73 | 36.17 | 33.29 |
Free Cash Flow |
1,359.00 | 909.00 | 864.00 | 1,314.00 | 1,830.00 | 1,587.00 | 843.00 | 817.00 | 923.00 | 823.00 |
Working Capital |
100.00 | 223.00 | 557.00 | 347.00 | 988.00 | 1,282.00 | 500.00 | (95.00) | 249.00 | 550.00 |
Capital Expenditures |
(527.00) | (425.00) | (408.00) | (404.00) | (403.00) | (418.00) | (400.00) | (383.00) | (252.00) | (293.00) |
Net Current Asset Value |
(6,641.00) | (6,948.00) | (5,308.00) | (5,009.00) | (4,387.00) | (4,159.00) | (4,666.00) | (4,346.00) | (4,242.00) | (3,909.00) |
EV/EBIT |
15.75 | 16.65 | 15.69 | 15.22 | 10.40 | 9.55 | 14.53 | 13.70 | 14.76 | 12.78 |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 | 0.04 |
Price to Operating Income |
12.38 | 12.44 | 12.50 | 12.65 | 9.08 | 8.10 | 11.62 | 10.29 | 11.63 | 10.14 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.26 | 0.23 | 0.24 | 0.25 | 0.24 | 0.22 | 0.23 | 0.24 | 0.24 | 0.24 |
Cash ROIC |
10.22% | 6.69% | 7.36% | 12.85% | 16.10% | 13.24% | 7.24% | 8.79% | 10.40% | 9.40% |
Accounts Receivable Turnover |
8.14 | 7.85 | 7.69 | 7.51 | 7.29 | 7.31 | 7.45 | 7.78 | 8.00 | 7.90 |
Accounts Payable Turnover |
4.92 | 4.82 | 4.50 | 4.31 | 4.07 | 4.34 | 4.89 | 4.82 | 4.73 | 4.64 |
Inventory Turnover |
39.10 | 35.07 | 32.46 | 32.25 | 30.53 | 33.55 | 45.38 | 50.78 | 53.32 | 55.61 |
Average Days of Payables |
79.24 | 76.77 | 80.02 | 79.00 | 88.77 | 102.70 | 75.43 | 75.65 | 78.97 | 77.10 |
Days of Inventory on Hand |
9.36 | 10.35 | 11.19 | 10.87 | 11.54 | 14.02 | 8.91 | 7.34 | 7.35 | 6.48 |
Average Receivables |
1,356.00 | 1,257.00 | 1,202.50 | 1,316.50 | 1,479.00 | 1,291.50 | 1,037.50 | 968.00 | 925.00 | 913.50 |
Average Payables |
1,497.00 | 1,376.50 | 1,377.50 | 1,498.00 | 1,616.50 | 1,337.00 | 1,031.00 | 1,021.00 | 998.00 | 994.50 |
Average Inventory |
188.50 | 189.00 | 191.00 | 200.00 | 215.50 | 173.00 | 111.00 | 97.00 | 88.50 | 83.00 |
Average Assets |
16,189.00 | 15,087.50 | 13,429.50 | 13,224.00 | 13,818.50 | 13,434.50 | 11,923.00 | 10,753.00 | 10,301.50 | 10,031.00 |
Average Common Equity |
7,009.50 | 6,577.50 | 6,136.00 | 6,206.50 | 6,646.00 | 6,248.00 | 5,477.00 | 5,111.00 | 4,807.50 | 4,686.50 |
Columns are period end dates